US Tariff Impact on Indian Pharma Stocks: Cipla, Biocon, Lupin Under Pressure
The Nifty Pharma index declined 2.67% intraday on Friday after US President Donald Trump announced a 100% tariff on the sector, affecting Indian pharma stocks like Cipla, Biocon, and Lupin.